ALIVE Israel Healthtech Fund

Venture Capital Active Savyon, Israel Est. 2020
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
10
in our dataset
Rounds participated
12
Rounds led
7
Rounds' value
$211.4M
total disclosed, rounds participated
Stages
SAFE, B Round, D Round, G Round, A Round, F Round, C Round, E Round

About

ALIVE Israel Healthtech Fund is a mid-to-late-stage healthtech investment fund that operates through a strategic partnership model to support the clinical and commercial expansion of its portfolio companies. The fund focuses on Medtech, Digital Health, and Bio Convergence, with a strong emphasis on the U.S. market and global outreach. By collaborating with hospital chains, HMOs, financial institutions, venture capital firms, and crossover funds, the fund facilitates regulatory progress, business plan execution, and strategic growth for its portfolio companies.

Portfolio · 10

Navina
AI-based Patient Profiles for Primary Care
Led ★ 2 rounds $77.0M committed Latest: 2025-03
Vessi Medical
Cryotherapy for treatment of urological tissue
Led ★ 1 round $16.5M committed Latest: 2024-02
Nevia bio
Early Diagnostic Solutions for Gynecological Disease
2 rounds $3.1M committed Latest: 2023-08
Append Medical
Trans-septal Left Atrial Appendage Closure Device
1 round $4.3M committed Latest: 2023-07
WISDO HEALTH
Social Health Platform
Led ★ 1 round $5.0M committed Latest: 2023-01
OncoHost
Precision Diagnostics and Predictive Biomarker Development
Led ★ 1 round $35.0M committed Latest: 2022-05
Beyeonics
Surgical Visualization Technologies
Led ★ 1 round Latest: 2021-10
Cynerio
Cybersecurity for Healthcare Providers
Led ★ 1 round $30.0M committed Latest: 2021-05
Innovalve Bio Medical
Catheter-based Heart Valve Therapies
Led ★ 1 round $10.5M committed Latest: 2020-08
Medisafe
Medication Management Platform
1 round $30.0M committed Latest: 2020-05

Investment activity

3 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences10
Cyber Security1

Funds · 3

  • 3 — $1 Nov 2025
  • ALIVE Next Fund II — $1 Jul 2024
  • ALIVE I — $110M Aug 2020

Q&A

What is ALIVE Israel Healthtech Fund's primary investment focus?
ALIVE Israel Healthtech Fund is a mid-to-late-stage healthtech investment fund focusing on Medtech, Digital Health, and Bio Convergence, with a strong emphasis on the U.S. market and global outreach.
When was ALIVE Israel Healthtech Fund founded?
ALIVE Israel Healthtech Fund was founded in 2020.
Which notable exits has ALIVE Israel Healthtech Fund achieved recently?
ALIVE Israel Healthtech Fund has seen two notable exits in 2025: WISDO HEALTH was acquired by Talkspace in October 2025, and Cynerio was acquired by Axonius for $180M in July 2025.
What was a significant exit for ALIVE Israel Healthtech Fund in 2024?
In July 2024, ALIVE Israel Healthtech Fund saw Innovalve Bio Medical acquired by Edwards Lifesciences for $300M.
Which funds has ALIVE Israel Healthtech Fund raised?
ALIVE Israel Healthtech Fund raised ALIVE I, a $110M fund in August 2020. They also have ALIVE Next Fund II, raised in July 2024, and Fund 3, raised in November 2025.
Who are the co-founders and managing partners of ALIVE Israel Healthtech Fund?
The co-founders and managing partners of ALIVE Israel Healthtech Fund include Michel Habib, Dudi Klein, Ari Shamiss, and Rafael Beyar.
What are some of ALIVE Israel Healthtech Fund's portfolio companies?
ALIVE Israel Healthtech Fund's portfolio includes companies like Magenta Medical, which has raised $224.9M, and Navina, which has raised $99M.
What investment stages does ALIVE Israel Healthtech Fund typically participate in?
ALIVE Israel Healthtech Fund participates in various investment stages, including SAFE, Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)